Physician profile
Anna L Heitz
NPI 1528558954
$3,032.24
in general payments reported to CMS, 2019-2025
12 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,598 · 2023: $54.27 · 2024: $110 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749 · Travel and Lodging: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.95 |
| Travel and Lodging | $684.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,614.69 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Cvrx, INC. | $1,168.08 | 2024-2025 | Barostim Neo System |
| Daxor Corporation | $40.82 | 2024-2025 | Bva-100 |
| Scpharmaceuticals INC. | $38.89 | 2025 | |
| Janssen Pharmaceuticals, INC | $29.76 | 2022-2023 | Xarelto |
| Boston Scientific Corporation | $27.30 | 2024 | Watchman Access System |
| Amgen INC. | $22.63 | 2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.57 | 2022 | |
| Medtronic, INC. | $21.63 | 2024 | Corevalve Evolut R |
| Ancora Heart, INC. | $16.35 | 2024 | Accucinch |
| Genzyme Corporation | $15.60 | 2023 | |
| Ionis Pharmaceuticals, INC. | $13.92 | 2025 | Tryngolza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Heitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.